[HTML][HTML] Neutrophils and COVID-19: The road so far
LHA Cavalcante-Silva, DCM Carvalho… - International …, 2021 - Elsevier
The SARS-Cov2 infection triggers a multisystem inflammatory disorder, knowing as COVID-
19, a pandemic disease. This disease is characterized by acute respiratory distress …
19, a pandemic disease. This disease is characterized by acute respiratory distress …
[HTML][HTML] Neutrophils in COVID-19
N Reusch, E De Domenico, L Bonaguro… - Frontiers in …, 2021 - frontiersin.org
Strong evidence has been accumulated since the beginning of the COVID-19 pandemic that
neutrophils play an important role in the pathophysiology, particularly in those with severe …
neutrophils play an important role in the pathophysiology, particularly in those with severe …
[HTML][HTML] Neutrophils in COVID-19: not innocent bystanders
E McKenna, R Wubben, JM Isaza-Correa… - Frontiers in …, 2022 - frontiersin.org
Unusually for a viral infection, the immunological phenotype of severe COVID-19 is
characterised by a depleted lymphocyte and elevated neutrophil count, with the neutrophil …
characterised by a depleted lymphocyte and elevated neutrophil count, with the neutrophil …
Neutrophils in COVID-19: recent insights and advances
J Li, K Zhang, ye Zhang, Z Gu, C Huang - Virology journal, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can lead to acute …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can lead to acute …
Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
HF Peñaloza, JS Lee, P Ray - PLoS pathogens, 2021 - journals.plos.org
The Coronavirus Disease 2019 (COVID-19) is caused by the betacoronavirus Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus that can mediate asymptomatic or …
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus that can mediate asymptomatic or …
Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19
The COVID-19 pandemic is progressing worldwide with an alarming death toll. There is an
urgent need for novel therapeutic strategies to combat potentially fatal complications …
urgent need for novel therapeutic strategies to combat potentially fatal complications …
COVID‐19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps
Coronavirus disease 2019 (COVID‐19) is a virus‐induced respiratory disease that may
progress to acute respiratory distress syndrome (ARDS) and is triggered by …
progress to acute respiratory distress syndrome (ARDS) and is triggered by …
Increased peripheral blood neutrophil activation phenotypes and neutrophil extracellular trap formation in critically ill coronavirus disease 2019 (COVID-19) patients: a …
Background Increased inflammation has been well defined in coronavirus disease 2019
(COVID-19), while definitive pathways driving severe forms of this disease remain uncertain …
(COVID-19), while definitive pathways driving severe forms of this disease remain uncertain …
[HTML][HTML] Neutrophils and COVID-19: active participants and rational therapeutic targets
J Hazeldine, JM Lord - Frontiers in immunology, 2021 - frontiersin.org
Whilst the majority of individuals infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to …
coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to …
[HTML][HTML] Targeting neutrophils to treat acute respiratory distress syndrome in coronavirus disease
This review describes targeting neutrophils as a potential therapeutic strategy for acute
respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID …
respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID …